27 / 36
Page 58
Cancer Therapy & Biomarkers 2016
Day 3 December 07, 2016
Session Chair
David Chafin
Roche Tissue Diagnostics (RTD), USA
Session Chair
Jianhua Luo
University of Pittsburgh School of Medicine, USA
Sessions:
Cancer Cell Biology, Diagnosis and Applied Research|Biomarkers in Clinical
Research and Development|Cancer Therapy and Clinical Cancer Research
Organ-Specific cancer |Complementary and Alternative Medicine (CAM)
Cancer Nanotechnology|Global Cancer Epidemiology
Session Introduction
Title:
Gut microbiota modulates cisplatin mediated systemic toxicity
Soumen Roy,
Cancer and Inflammation Program, NCI, NIH, USA
Title:
Formulation of liposomes for oral delivery of phyllanthin and hypophyllanthin
Thahera Parveen Dandu,
Oman Pharmaceutical Products (Gulf), Oman
Title:
A conceptual study on understanding an ayurvedic concept of cancer and its supportive
treatment majors in Ayurveda
Nikhil M Dongarkar,
Parul Institute of Ayurved, India
Title:
Method development for quantification of circulating cell free HPV DNA
Zhigang Kang,
National Cancer Institute, Bethesda, USA
Title:
Predicting wound healing complications: a personalized medicine approach to wound
care
Kara Spiller,
Drexel University, USA
Title:
The comprehensive analysis of complex genomic data such as exome sequencing
presents several challenges to a clinical laboratory
Avni Santani,
Children's Hospital of Philadelphia, USA
Title:
Biomarker concentration acting as the indicators for chemicals health risk assessment:
The case study in Thailand
Nalinee Sripaung,
Bureau of Occupational and Environmental Diseases-Ministry of Public
Health, Thailand
Title:
The evaluation of concentration of calprotectin, in pleural fluid with causes of exudative
pleural effusion
Mohammad Reza Hashempour,
Azar Hospital-Golestan University of Medical Sciences, Iran
Title:
Regulatory aspetcs of co-development of biomarkers and companion diagnostics
Soma Ghosh,
Center for Device and Radiological Health, FDS, USA